retatrutide clinical trial phase Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Pharmaceutical Executive Daily: Eli Lilly

Resistance training two to three times per week, combined with adequate protein intake, sends muscle-building signals that counteract the catabolic effects of caloric restriction

The foundation's annual youth survey found that more than half of all young people aged 12-18 reported being dissatisfied with their bodies in 2024

Unlike prescription medications, supplements dont have to prove that theyre safe and effective, and the FDA doesnt regulate them the same way

All dosage information below comes from published clinical trial data

This marked a turning point, shifting GLP-1 agonists from diabetes-focused therapies to primary obesity treatments

Dosing frequency depends on the specific GLP-1 prescribed: Once-daily injections (e } What to Expect After Starting GLP-1 Injections Its common for licensed providers to start patients at a lower dose, which may minimize side effects and build tolerance